➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Drugs in MeSH Category Neurotransmitter Uptake Inhibitors

Email this page to a colleague

« Back to Dashboard

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Watson Labs	AMOXAPINE	amoxapine	TABLET;ORAL	072691-003	Aug 28, 1992		RX	No	No	⤷ Free Forever Trial	⤷ Free Forever Trial				⤷ Free Forever Trial
Lederle	ASENDIN	amoxapine	TABLET;ORAL	018021-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Free Forever Trial	⤷ Free Forever Trial				⤷ Free Forever Trial
Upsher Smith Labs	AMOXAPINE	amoxapine	TABLET;ORAL	072943-001	Jun 28, 1991		DISCN	No	No	⤷ Free Forever Trial	⤷ Free Forever Trial				⤷ Free Forever Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Harvard Business School

Dow

McKinsey

Moodys

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.